The evolving role of stereotactic body radiation therapy for head and neck cancer: where do we stand?

I Mohamad, I Karam, A El-Sehemy, I Abu-Gheida… - Cancers, 2023 - mdpi.com
Simple Summary Currently, Stereotactic Body Radiation Therapy (SBRT) is reserved for
head and neck cancer (HNC) patients who are not suitable candidates for conventional …

Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck–a case series and review of …

M Olmos, R Lutz, TO Büntemeyer, J Glajzer… - Frontiers in …, 2022 - frontiersin.org
Background Prognosis of patients with recurrent or metastatic head and neck cancer is
generally poor. Adjuvant immunotherapy (IT) featuring immune checkpoint inhibition (ICI) is …

Mutated HRAS activates YAP1–AXL signaling to drive metastasis of head and neck cancer

S Jagadeeshan, M Prasad, M Badarni, T Ben-Lulu… - Cancer research, 2023 - AACR
The survival rate for patients with head and neck cancer (HNC) diagnosed with cervical
lymph node (cLN) or distant metastasis is low. Genomic alterations in the HRAS oncogene …

Clinical characteristics and predictive outcomes of recurrent nasopharyngeal carcinoma—a lingering pitfall of the long latency

YH Chen, SD Luo, SC Wu, CN Wu, TJ Chiu, YM Wang… - Cancers, 2022 - mdpi.com
Simple Summary Unlike other head and neck cancers, nasopharyngeal carcinoma (NPC)
with long-latent recurrence (> five years) is not rare. This study aims to investigate the …

The head and neck tumor segmentation in PET/CT based on multi-channel attention network

G Wang, Z Huang, H Shen, Z Hu - … Head and Neck Tumor Segmentation in …, 2021 - Springer
Automatic segmentation of head and neck (H&N) tumors plays an important and challenging
role in clinical practice and radiomics researchers. In this paper, we developed an …

[HTML][HTML] Squamous cell carcinoma metastatic to the lymph nodes of the parapharyngeal space: case series and systematic review

M Fermi, C Botti, F Chiari, A Abeshi… - ACTA …, 2024 - pmc.ncbi.nlm.nih.gov
Objective Parapharyngeal space (PPS) is a rare and unusual site of head and neck
squamous cell carcinoma (SCC) metastases. Treatment strategy for PPS metastases is still …

Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?

I Tinhofer, S Staudte, S George - Current Opinion in Oncology, 2023 - journals.lww.com
Liquid biopsy in head neck cancer: ready for clinical routin... : Current Opinion in Oncology
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics? : Current Opinion in …

Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head …

C Zhou, H Deng, Y Fang, Z Wei, Y Shen, S Qiu, D Ye… - Heliyon, 2023 - cell.com
T cells are among the most potent anti-tumor cells that are found in humans. Our study
sought to develop a reliable signature incorporating T cell marker genes (TMGs) for …

Systematic analysis of molecular subtypes and immune prediction based on CD8 T cell pattern genes based on head and neck cancer

L Yanwei, F He, S Liu, Z Pan - Journal of Oncology, 2022 - Wiley Online Library
CD8+ T lymphocytes, also known as cytotoxic T lymphocytes, are the most powerful
antitumour cells in the human body. Patients with head and neck squamous cell carcinoma …

Clinical practice guidelines for the management of recurrent head and neck cancer: a systematic review and quality appraisal

E De Ravin, J Lu, M Salmon, S Venkatesh… - European Archives of …, 2023 - Springer
Purpose Recurrent head and neck cancer (HNC) has a significant global disease burden
and its treatment is complex. Multiple clinical practice guidelines (CPGs) have been …